Avid Bioservices (CDMO) News Today $12.36 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Fmr LLC Raises Stake in Avid Bioservices, Inc. (NASDAQ:CDMO)Fmr LLC increased its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 1,010.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 70,096 shares of the biopharmaceutical company's stock after pDecember 18 at 3:11 AM | marketbeat.comLord Abbett & CO. LLC Invests $6.19 Million in Avid Bioservices, Inc. (NASDAQ:CDMO)Lord Abbett & CO. LLC purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 544,300 shares of the biopharmaceutiDecember 17 at 5:19 AM | marketbeat.comCraig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)December 12, 2024 | markets.businessinsider.comAvid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024December 10, 2024 | globenewswire.comCraig-Hallum Issues a Hold Rating on Avid Bioservices (CDMO)December 7, 2024 | markets.businessinsider.comStephens Downgrades Avid Bioservices (NASDAQ:CDMO) to HoldStephens lowered Avid Bioservices from a "strong-buy" rating to a "hold" rating in a report on Wednesday.December 6, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases 1,142,756 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Point72 Asset Management L.P. raised its position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 42.8% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,815,806 shares of the biopharmaceutical company's stoDecember 5, 2024 | marketbeat.comParkman Healthcare Partners LLC Raises Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)Parkman Healthcare Partners LLC boosted its position in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 15.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 719,965 shares of the biopharmaceutical company's stock after acquiring an additional 98December 4, 2024 | marketbeat.comCinctive Capital Management LP Has $3.44 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO)Cinctive Capital Management LP grew its position in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 98.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 302,651 shares of the biopharmaceutical company's stock after purchasing anDecember 3, 2024 | marketbeat.comCannell Capital to vote against Avid Biosciences takeoverDecember 2, 2024 | msn.comCDMO Investors Have the Opportunity to Join Investigation of Avid Bioservices, Inc. with the Schall Law FirmDecember 2, 2024 | businesswire.comCannell Capital LLC Intends to Vote Against Proposed Acquisition of Avid Bioservices by GHO Capital and Ampersand CapitalDecember 2, 2024 | finance.yahoo.comLifecore Biomedical: An Interesting CDMO Pure PlayDecember 1, 2024 | seekingalpha.comFisher Asset Management LLC Acquires 155,419 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Fisher Asset Management LLC boosted its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 63.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 401,081 shares of the biopharmaceutical company'sNovember 29, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Receives Consensus Rating of "Hold" from BrokeragesAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and two have assigned a buyNovember 24, 2024 | marketbeat.com185,120 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Acquired by Phocas Financial Corp.Phocas Financial Corp. bought a new stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 185,120 shares of the biopharmaceutical company's stock, valued at approNovember 20, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LPRoyce & Associates LP grew its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 7.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 789,227 shares of the biopharmaceutical company's stock afNovember 18, 2024 | marketbeat.comAvid Bioservices, Inc. (CDMO): A Bull Case TheoryNovember 17, 2024 | msn.comPunch and Associates sends letter to Board of Directors of Avid Bioservices, Inc.November 14, 2024 | businesswire.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by GSA Capital Partners LLPGSA Capital Partners LLP increased its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 97.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 153,070 shares of the biopharmaceutical company's stock after buying an additional 75,473 shares duNovember 13, 2024 | marketbeat.comAVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMONovember 9, 2024 | businesswire.comTustin-based Biotech Company Avid Bioservices Inc. To Go Private in $850M DealNovember 9, 2024 | latimes.comAvid Bioservices: Take-Private Deal At A Reasonable Price, Maintaining BuyNovember 9, 2024 | seekingalpha.comAvid Bioservices (NASDAQ:CDMO) Sees Strong Trading Volume - What's Next?Avid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - What's Next?November 8, 2024 | marketbeat.comRBC Capital Downgrades Avid Bioservices (CDMO)November 8, 2024 | msn.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avid Bioservices, Inc. – CDMONovember 8, 2024 | globenewswire.comAvid Bioservices to be Acquired in $1.1 Billion DealNovember 8, 2024 | markets.businessinsider.comShareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public ShareholdersNovember 8, 2024 | businesswire.comGHO and Ampersand Capital to acquire Avid BioservicesNovember 7, 2024 | msn.comAvid Bioservices to be acquired for $1.1B in cash by GHO, AmpersandNovember 7, 2024 | msn.comCraig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)November 7, 2024 | markets.businessinsider.comCDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to ShareholdersNovember 7, 2024 | businesswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc.November 7, 2024 | prnewswire.comAvid Bioservices (NASDAQ:CDMO) Shares Gap Up - What's Next?Avid Bioservices (NASDAQ:CDMO) Shares Gap Up - Should You Buy?November 7, 2024 | marketbeat.comCDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital PartnersNovember 7, 2024 | globenewswire.comWilliam Blair Reiterates Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)William Blair reaffirmed a "market perform" rating on shares of Avid Bioservices in a research report on Thursday.November 7, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Receives "Sector Perform" Rating from Royal Bank of CanadaRoyal Bank of Canada restated a "sector perform" rating and issued a $12.50 target price (up from $12.00) on shares of Avid Bioservices in a research note on Thursday.November 7, 2024 | marketbeat.comAvid Bioservices to be taken private by GHO, Ampersand in $1.1 billion dealNovember 6, 2024 | msn.comAvid Bioservices to Go Private in $1.1 Billion DealNovember 6, 2024 | msn.comAvid Bioservices to be acquired by GHO and Ampersand for about $1.1 blnNovember 6, 2024 | reuters.comAvid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion TransactionNovember 6, 2024 | globenewswire.com1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Acquired by Emerald Advisers LLCEmerald Advisers LLC purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,448,916 shares of the biopharmaceutical coNovember 3, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) have received an average rating of "Moderate Buy" from the five ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buyOctober 30, 2024 | marketbeat.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,031 Shares of StockOctober 12, 2024 | insidertrades.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC grew its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 112.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 341,311 shares of the biopharmaceutical company's stock after purchasing anOctober 12, 2024 | marketbeat.comRichard A. Richieri Sells 2,031 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) insider Richard A. Richieri sold 2,031 shares of the business's stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $10.05, for a total value of $20,411.55. Following the completion of the sale, the insider now directly owns 37,704 shares of the company's stock, valued at approximately $378,925.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.October 11, 2024 | marketbeat.comSquarepoint Ops LLC Sells 341,119 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Squarepoint Ops LLC trimmed its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 87.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,933 shares of the biopharmaceutical company's stock after selliOctober 11, 2024 | marketbeat.comMarshall Wace LLP Acquires New Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)Marshall Wace LLP acquired a new stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 195,461 shares of the biophOctober 7, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comMillennium Management LLC Acquires 695,512 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Millennium Management LLC increased its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 15.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,099,529 shares of the biopharmaceutical company'sOctober 3, 2024 | marketbeat.com Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. CDMO Media Mentions By Week CDMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDMO News Sentiment▼0.150.69▲Average Medical News Sentiment CDMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDMO Articles This Week▼32▲CDMO Articles Average Week Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XENE News FOLD News MRUS News ACAD News MOR News ZLAB News GMTX News VERA News BHC News ARWR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDMO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
